×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IVVD – invivyd, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IVVD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
08:12 am
ivvd
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
Medium
Report
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
12/23
08:12 am
ivvd
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
Medium
Report
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
12/23
07:05 am
ivvd
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Medium
Report
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
12/23
07:01 am
ivvd
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Medium
Report
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
12/23
05:31 am
ivvd
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
Low
Report
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
12/22
06:01 am
ivvd
Invivyd (NASDAQ:IVVD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
High
Report
Invivyd (NASDAQ:IVVD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/19
01:33 am
ivvd
How Recent Clinical Progress Is Rewriting the Story for Invivyd [Yahoo! Finance]
Low
Report
How Recent Clinical Progress Is Rewriting the Story for Invivyd [Yahoo! Finance]
12/16
04:38 pm
ivvd
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
07:08 am
ivvd
Form 8-K Invivyd, Inc. For: Dec 23
Medium
Report
Form 8-K Invivyd, Inc. For: Dec 23
11/25
04:02 pm
ivvd
Form SCHEDULE 13G Invivyd, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SCHEDULE 13G Invivyd, Inc. Filed by: PERCEPTIVE ADVISORS LLC
11/24
11:16 am
ivvd
Form 8-K Invivyd, Inc. For: Nov 24
Low
Report
Form 8-K Invivyd, Inc. For: Nov 24
11/20
04:22 pm
ivvd
Form 4 Invivyd, Inc. For: Nov 19 Filed by: MCLAUGHLIN KEVIN F
Low
Report
Form 4 Invivyd, Inc. For: Nov 19 Filed by: MCLAUGHLIN KEVIN F
11/19
05:25 pm
ivvd
Form 8-K Invivyd, Inc. For: Nov 17
Medium
Report
Form 8-K Invivyd, Inc. For: Nov 17
11/19
04:30 pm
ivvd
Form SCHEDULE 13D/A Invivyd, Inc. Filed by: Adimab, LLC
Medium
Report
Form SCHEDULE 13D/A Invivyd, Inc. Filed by: Adimab, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: